Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Côlon ou Rectum (colorectal)
- | Specialty :
- Thérapies Ciblées
- Chimiothérapie
Extract
A randomised, double-blind, multicentre phase II/III study to compare the efficacy of cediranib (recentin™, AZD2171) in combination with 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX), to the efficacy of bevacizumab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer.
Scientific Abstract
en cours d'intégration;